PEX3

Peroxisomal biogenesis factor 3 · P56589 · PEX3 on Sugi Atlas →

0 patent compounds predicted against PEX3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PEX3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone. PHASE4COMPLETED
Betaine and Peroxisome Biogenesis Disorders PHASE3COMPLETED
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
Hydroxychloroquine Administration for Reduction of Pexophagy PHASE2COMPLETED
Cholic Acid for Hepatic Steatosis in Lipodystrophy PHASE2COMPLETED
Vitreous Proteomics of Patients Suffering From Pseudoexfoliation Syndrome nanACTIVE_NOT_RECRUITING
Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA Fragmentation in Pseudoexfoliation (PEX) Glaucoma nanCOMPLETED
RCDP Natural History Study nanUNKNOWN
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. nanUNKNOWN
Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney Disease nanUNKNOWN
Longitudinal Prospective Natural History Study of Retinopathy in Zellweger Spectrum Disorder nanRECRUITING
Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study nanCOMPLETED
Evaluation of a New Strategy for the Diagnosis of Peroxisomal Diseases nanCOMPLETED
for Adipose Tissue DIabetes VAriants (fATDIVA) nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Investigating the Genetic Basis of Pseudoexfoliation Syndrome, Angle-closure Glaucoma and Primary Open-angle Glaucoma nanRECRUITING
The LD Lync Study - Natural History Study of Lipodystrophy Syndromes nanRECRUITING
Chronic Obstructive Pulmonary Disease Gene Localization nanCOMPLETED
Familial Partial Lipodystrophy Study nanCOMPLETED
Evolution of Visual Impairment During Pseudoxanthoma Elasticum nanCOMPLETED
Clinical and Laboratory Study of Methylmalonic Acidemia nanRECRUITING
Characterization and Outcome of Children With Leukodystrophy: An Observational Study at Sohag University Hospital nanUNKNOWN
Identification of Gulf War Illness (GWI) Biomarkers nanCOMPLETED
Peroxisomal Defects and Familial Risk for Bipolar Disorder nanCOMPLETED
Human Liver ORganoids as a Model to Study the Development of Non-Alcoholic SteatOhepatitis (NASH) nanRECRUITING
OEA for Targeting Lipid Metabolism in GWI nanCOMPLETED
Genetic Causes and Clinical Features of Childhood Interstitial Lung Diseases in China nanCOMPLETED
Implementation of Molecular Diagnostic Pathways nanUNKNOWN
Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone. nanCOMPLETED
Biomarker Research in Inherited Movement Disorders nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a PEX3 binder may also engage these)

ProteinNameSimilarity
Q9JJK3 1.000 Q9JJK3 →
A6H7C2 1.000 A6H7C2 →
Q9QXY9 1.000 Q9QXY9 →
Q60HE1 1.000 Q60HE1 →
Q9JJK4 0.999 Q9JJK4 →
Q8IWV8 0.973 Q8IWV8 →
Q5R903 0.968 Q5R903 →
Q9H3E2 0.967 Q9H3E2 →
Q8BHY8 0.967 Q8BHY8 →
A9JRA0 0.967 A9JRA0 →
Q5R644 0.966 Q5R644 →
USP9X Ubiquitin carboxyl-terminal hydrolase 9X 0.966 landscape →
Q7TPD0 0.965 Q7TPD0 →
Q9Y5W7 0.965 Q9Y5W7 →
O35841 0.965 O35841 →
Q91W96 0.964 Q91W96 →
Q8BKT7 0.964 Q8BKT7 →
Q8IZD9 0.963 Q8IZD9 →
Q8BWQ6 0.962 Q8BWQ6 →
Q9Y5W8 0.962 Q9Y5W8 →
Q5R8N4 0.962 Q5R8N4 →
Q9R1D7 0.962 Q9R1D7 →
Q68E01 0.961 Q68E01 →
Q9I8I2 0.961 Q9I8I2 →
Q8C735 0.961 Q8C735 →
Q5TKA1 0.961 Q5TKA1 →
Q5ZJZ6 0.961 Q5ZJZ6 →
Q8CIQ7 0.960 Q8CIQ7 →
Q6WKZ8 0.960 Q6WKZ8 →
Q7Z3J2 0.960 Q7Z3J2 →